Caplight Directory>Companies>Sable-preview>Namepros


Sable

Sable

Private
New York City, New YorkHealthcare & Life Scienceshttp://sable.bio/

Last Round

Pre Seed

Jan 19, 2026

Total Funding Raised

$5.8M

Company Overview

Sable is a biotech company that develops topical consumer beauty solutions for body contouring and aesthetic longevity.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Medical AI, Biotechnology

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

drug safety predictionpredictive toxicologyAI drug discoveryin silico toxicologysafety assessmentdrug discovery platformclinical trial riskcausal inferencelarge language modelsLLMsbiomedical data analysisdrug developmentpharma techB2B SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sable Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Sable Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Pre SeedJan 19, 2026
Pre SeedJan 30, 2024
SeedJul 14, 2022
SeedFeb 27, 2020
Pre SeedJun 9, 2019
View all Funding Rounds

Sable Investors

Notable investors and investment history

InvestorRounds
XG VenturesSeed
Red Sea VenturesSeed
Outbound VenturesSeed, Pre Seed
Laidlaw Scholars VenturesSeed
EmlesSeed
Twenty Two VenturesSeed
Columbia University in the City of New YorkSeed
View all Investors

Sable Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sable Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sable's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Year Founded2026
Last FundingJan 19, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.